55 related articles for article (PubMed ID: 20510408)
21. Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians.
Hirata-Dulas CA; Rith-Najarian SJ; McIntyre MC; Ross C; Dahl DC; Keane WF; Kasiske BL
Clin Nephrol; 1996 Aug; 46(2):92-8. PubMed ID: 8869785
[TBL] [Abstract][Full Text] [Related]
22. Does intensive glycemic control improve cardiovascular outcomes?
Pendergrass M
Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
[No Abstract] [Full Text] [Related]
23. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors.
Daousi C; Casson IF; Gill GV; MacFarlane IA; Wilding JP; Pinkney JH
Postgrad Med J; 2006 Apr; 82(966):280-4. PubMed ID: 16597817
[TBL] [Abstract][Full Text] [Related]
24. Increased arterial stiffness is associated with reduced plasma levels of beta-carotene in treated hypertensive patients with type 2 diabetes mellitus.
Chung HK; Kang B; Lee JH; Shim JY; Park S; Lee SH; Park YK; Park E; Chung N; Shin MJ
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):e9-e11. PubMed ID: 19505810
[No Abstract] [Full Text] [Related]
25. The role of the thiazolidinediones in the practical management of patients with type 2 diabetes and cardiovascular risk factors.
Edelman SV
Rev Cardiovasc Med; 2003; 4 Suppl 6():S29-37. PubMed ID: 14668701
[TBL] [Abstract][Full Text] [Related]
26. Relationship between obesity, hypertension and diabetes, and health-related quality of life among the elderly.
Banegas JR; López-García E; Graciani A; Guallar-Castillón P; Gutierrez-Fisac JL; Alonso J; Rodríguez-Artalejo F
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):456-62. PubMed ID: 17568249
[TBL] [Abstract][Full Text] [Related]
27. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain.
Orozco-Beltrán D; Gil-Guillen VF; Quirce F; Navarro-Perez J; Pineda M; Gomez-de-la-Cámara A; Pita S; Diez-Espino J; Mateos J; Merino J; Serrano-Rios M;
Int J Clin Pract; 2007 Jun; 61(6):909-15. PubMed ID: 17504353
[TBL] [Abstract][Full Text] [Related]
28. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
29. Early intensive cardiovascular risk management in young people with type 2 diabetes.
Song SH; Gray TA
Diabetes Res Clin Pract; 2011 Jun; 92(3):e70-2. PubMed ID: 21420751
[TBL] [Abstract][Full Text] [Related]
30. [What do type II diabetics know about cardiovascular risk factors? Relationship with the level of control of these factors].
Navarro Oliver AF; Martínez Navarro A; Martínez Navarro MA; Leal Hernández M
Semergen; 2014 Sep; 40(6):352-3. PubMed ID: 25016943
[No Abstract] [Full Text] [Related]
31. The diabetes-heart disease connection and what it means for you. Understand the interactions between these two conditions.
Harv Heart Lett; 2014 Apr; 24(8):5. PubMed ID: 25108931
[No Abstract] [Full Text] [Related]
32. [Degree of fulfillment of the objectives of metabolic control and cardiovascular risk factors in patients with type 2 diabetes in an area of primary attention].
González Sarmiento E; Vielba Dueñas B; Fernández Galante I; Manso García S; San Pedro Martín Y; Vielba Dueñas D; Fernández González R
An Med Interna; 2005 Nov; 22(11):520-4. PubMed ID: 16454584
[TBL] [Abstract][Full Text] [Related]
33. South Asia's governments exhorted to focus on CVD.
Srivastava R
Lancet; 2002 Mar; 359(9309):858. PubMed ID: 11897295
[No Abstract] [Full Text] [Related]
34. Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the Outpatient Diabetic Clinic of Kenyatta National Hospital, Nairobi.
Joshi MD; Amayo EO
East Afr Med J; 2006 Jul; 83(7):405-6; author reply 406-7. PubMed ID: 17089502
[No Abstract] [Full Text] [Related]
35. [Prevention of CV complications in DM2 - which targets should be used?].
Jacob S
MMW Fortschr Med; 2019 Nov; 161(19):37-41. PubMed ID: 31691223
[No Abstract] [Full Text] [Related]
36. [Introduction. Justification].
Núñez-Cortés JM
Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():1-2. PubMed ID: 25043538
[No Abstract] [Full Text] [Related]
37. [Integral control of cardiovascular risk factors in type 2 diabetes in the Pallars Jussà and Sobirà regions (area of influence of the regional hospital of Pallars-Lleida)].
Porres LD; Solans MR; Oña MF; Morilla L; Isarn RM; Milian ES; Pujol LE
Rev Clin Esp; 2010; 210(7):332-7. PubMed ID: 20510408
[TBL] [Abstract][Full Text] [Related]
38. [Incidence, etiology and epidemiology of brucellosis in a rural area of the province of Lleida].
Serra Alvarez J; Godoy García P
Rev Esp Salud Publica; 2000; 74(1):45-53. PubMed ID: 10832390
[TBL] [Abstract][Full Text] [Related]
39. Management of type 2 diabetes mellitus: is it in accordance with the guidelines?
Chan GC; Ghazali O; Khoo EM
Med J Malaysia; 2005 Dec; 60(5):578-84. PubMed ID: 16515108
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular risk levels in general practice patients with type 2 diabetes in rural and urban areas.
Wan Q; Harris MF; Powell-Davies G; Jayasinghe UW; Flack J; Georgiou A; Burns JR; Penn DL
Aust J Rural Health; 2007 Oct; 15(5):327-33. PubMed ID: 17760917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
